Onureg 200 mg Oral Tablet
RxNorm 2396770
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2396770 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Onureg 200 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Azacitidine 200 mg Oral Tablet [Onureg]
(Atom ID: 12436701)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
AzaCITIDine 200 mg Oral Tablet [Onureg]
(Atom ID: 12437766)
PSNPrescribable
Prescribable Name (PSN):
Onureg 200 mg Oral Tablet
(Atom ID: 12436702)
SYPrescribable
Synonym (SY):
Onureg 200 mg Oral Tablet
(Atom ID: 12436703)
Patient Education
Azacitidine
Azacitidine is used to treat acute myeloid leukemia (AML; cancer of the white blood cells) in adults who improved after chemotherapy, but who are unable to complete intensive curative therapy. Azacitidine is in a class of medications called demethylation agents. It works by helping the bone marrow to produce normal blood cells and by killing abnormal cells.
[Learn More]
* Please review the disclaimer below.